Clinical Trial Update: Efficacy and Safety of Talimogene Laherparepvec Neoadjuvant Treatment Plus Surgery Versus Surgery Alone for Melanoma [Phase 2]

View source ↗

Summary

Phase 2 trial updating efficacy and safety of talimogene laherparepvec plus neoadjuvant surgery versus surgery alone for completely resectable stage IIIB, IIIC,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Talimogene laherparepvec (talimogene laherparepvec)

Snippet

Sponsor: Amgen | Conditions: Completely Resectable Stage IIIB, IIIC, or IVM1a Melanoma | Phase 2 | Status: COMPLETED | Results posted: 2020-05-28